Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
103
Top-10 weight
40.58%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
35
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
995.2
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 499,479 | $459.41M | 8.84% |
| 2 | JOHNSON&JOHNSON | — | 1,550,240 | $378.94M | 7.29% |
| 3 | AstraZeneca PLC ORD USD0.25 | AZN LN | 1,221,946 | $238.63M | 4.59% |
| 4 | ABBVIE INC | — | 967,983 | $210.53M | 4.05% |
| 5 | UNITEDHEALTH GRP | — | 601,241 | $162.69M | 3.13% |
| 6 | Novartis AG | — | 971,619 | $148.41M | 2.86% |
| 7 | THERMO FISHER SCIENTIFIC INC | — | 265,275 | $130.39M | 2.51% |
| 8 | PRAXIS PRECISION MEDICINES INC | — | 394,970 | $127.26M | 2.45% |
| 9 | ARGENX SE SPONSORED ADR | — | 170,830 | $124.75M | 2.40% |
| 10 | ABBOTT LABS | — | 1,212,497 | $124.49M | 2.40% |
| 11 | BRIDGEBIO PHARMA INC | — | 1,551,141 | $115.19M | 2.22% |
| 12 | Roche Holding AG CHF0.001 | — | 290,904 | $114.90M | 2.21% |
| 13 | SANOFI | — | 1,116,972 | $107.72M | 2.07% |
| 14 | VERTEX PHARMACEUTICALS INC | — | 239,922 | $107.13M | 2.06% |
| 15 | REVOLUTION MEDICINES INC | — | 1,088,018 | $105.81M | 2.04% |
| 16 | INTUITIVE SURGICAL INC | — | 227,319 | $104.79M | 2.02% |
| 17 | HCA HEALTHCARE INC | — | 206,592 | $97.77M | 1.88% |
| 18 | BOSTON SCIENTIFIC CORP | — | 1,520,117 | $95.39M | 1.84% |
| 19 | AMGEN INC | — | 270,089 | $95.03M | 1.83% |
| 20 | Ascendis Pharma A/S | — | 375,183 | $85.82M | 1.65% |
| 21 | STRYKER CORP | — | 260,843 | $85.71M | 1.65% |
| 22 | DANAHER CORP | — | 448,567 | $85.05M | 1.64% |
| 23 | MADRIGAL PHARMACEUTICALS INC | — | 149,195 | $78.10M | 1.50% |
| 24 | CVS HEALTH CORP | — | 1,071,894 | $76.98M | 1.48% |
| 25 | MERCK & CO | — | 638,574 | $76.81M | 1.48% |
| 26 | PTC THERAPEUTICS INC | — | 1,024,173 | $69.78M | 1.34% |
| 27 | UNITED THERAPEUTICS CORP DEL | — | 116,721 | $69.21M | 1.33% |
| 28 | MCKESSON CORP | — | 79,818 | $69.07M | 1.33% |
| 29 | GILEAD SCIENCES INC | — | 471,681 | $65.74M | 1.26% |
| 30 | GLOBUS MEDICAL INC | — | 748,604 | $64.50M | 1.24% |
| 31 | MIRUM PHARMACEUTICALS INC | — | 685,482 | $63.32M | 1.22% |
| 32 | TEVA PHARMACEUTICAL IND ADR | — | 2,037,481 | $61.37M | 1.18% |
| 33 | VAXCYTE INC | — | 971,737 | $56.47M | 1.09% |
| 34 | MEDTRONIC PLC | — | 583,432 | $50.55M | 0.97% |
| 35 | ELEVANCE HEALTH INC | — | 165,285 | $48.39M | 0.93% |
| 36 | DYNE THERAPEUTICS INC | — | 2,528,224 | $45.84M | 0.88% |
| 37 | CENCORA INC | — | 139,138 | $43.71M | 0.84% |
| 38 | TRAVERE THERAPEUTICS INC | — | 1,432,164 | $42.55M | 0.82% |
| 39 | LANTHEUS HOLDING | — | 518,786 | $39.35M | 0.76% |
| 40 | MEDLINE INC-A | — | 864,511 | $38.47M | 0.74% |
| 41 | EDWARDS LIFESCIENCES CORP | — | 465,579 | $37.28M | 0.72% |
| 42 | DEXCOM INC | — | 561,491 | $35.26M | 0.68% |
| 43 | SOLENO THERAPEUTICS INC | — | 987,780 | $33.07M | 0.64% |
| 44 | APOGEE THERAPEUTICS INC | — | 379,608 | $31.95M | 0.61% |
| 45 | UCB SA | — | 104,561 | $31.49M | 0.61% |
| 46 | BECTON DICKINSON and CO | — | 181,577 | $28.55M | 0.55% |
| 47 | GLAUKOS CORP | — | 264,704 | $28.50M | 0.55% |
| 48 | STRUCTURE THERAPEUTICS INC ADR | — | 569,589 | $27.45M | 0.53% |
| 49 | IDEAYA BIOSCIENCES | — | 738,748 | $24.62M | 0.47% |
| 50 | PENUMBRA INC | — | 73,736 | $24.21M | 0.47% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.